Unacceptable Principal Diagnosis Codes
ICD-10-CM codes identified as unacceptable when used as principal diagnosis by MCE edit logic.
Source: Definitions of Medicare Code Edits v44.0, edit 9.
Advertisements
Codes on this list
2,666 codes, page 13 of 27.
- T47.5X6AUnderdosing of digestants, initial encounter
- T47.5X6DUnderdosing of digestants, subsequent encounter
- T47.5X6SUnderdosing of digestants, sequela
- T47.6X5AAdverse effect of antidiarrheal drugs, initial encounter
- T47.6X5DAdverse effect of antidiarrheal drugs, subsequent encounter
- T47.6X5SAdverse effect of antidiarrheal drugs, sequela
- T47.6X6AUnderdosing of antidiarrheal drugs, initial encounter
- T47.6X6DUnderdosing of antidiarrheal drugs, subsequent encounter
- T47.6X6SUnderdosing of antidiarrheal drugs, sequela
- T47.7X5AAdverse effect of emetics, initial encounter
- T47.7X5DAdverse effect of emetics, subsequent encounter
- T47.7X5SAdverse effect of emetics, sequela
- T47.7X6AUnderdosing of emetics, initial encounter
- T47.7X6DUnderdosing of emetics, subsequent encounter
- T47.7X6SUnderdosing of emetics, sequela
- T47.8X5AAdverse effect of other agents primarily affecting gastrointestinal system, initial encounter
- T47.8X5DAdverse effect of other agents primarily affecting gastrointestinal system, subsequent encounter
- T47.8X5SAdverse effect of other agents primarily affecting gastrointestinal system, sequela
- T47.8X6AUnderdosing of other agents primarily affecting gastrointestinal system, initial encounter
- T47.8X6DUnderdosing of other agents primarily affecting gastrointestinal system, subsequent encounter
- T47.8X6SUnderdosing of other agents primarily affecting gastrointestinal system, sequela
- T47.95XAAdverse effect of unspecified agents primarily affecting the gastrointestinal system, initial encounter
- T47.95XDAdverse effect of unspecified agents primarily affecting the gastrointestinal system, subsequent encounter
- T47.95XSAdverse effect of unspecified agents primarily affecting the gastrointestinal system, sequela
- T47.96XAUnderdosing of unspecified agents primarily affecting the gastrointestinal system, initial encounter
- T47.96XDUnderdosing of unspecified agents primarily affecting the gastrointestinal system, subsequent encounter
- T47.96XSUnderdosing of unspecified agents primarily affecting the gastrointestinal system, sequela
- T48.0X5AAdverse effect of oxytocic drugs, initial encounter
- T48.0X5DAdverse effect of oxytocic drugs, subsequent encounter
- T48.0X5SAdverse effect of oxytocic drugs, sequela
- T48.0X6AUnderdosing of oxytocic drugs, initial encounter
- T48.0X6DUnderdosing of oxytocic drugs, subsequent encounter
- T48.0X6SUnderdosing of oxytocic drugs, sequela
- T48.1X5AAdverse effect of skeletal muscle relaxants [neuromuscular blocking agents], initial encounter
- T48.1X5DAdverse effect of skeletal muscle relaxants [neuromuscular blocking agents], subsequent encounter
- T48.1X5SAdverse effect of skeletal muscle relaxants [neuromuscular blocking agents], sequela
- T48.1X6AUnderdosing of skeletal muscle relaxants [neuromuscular blocking agents], initial encounter
- T48.1X6DUnderdosing of skeletal muscle relaxants [neuromuscular blocking agents], subsequent encounter
- T48.1X6SUnderdosing of skeletal muscle relaxants [neuromuscular blocking agents], sequela
- T48.205AAdverse effect of unspecified drugs acting on muscles, initial encounter
- T48.205DAdverse effect of unspecified drugs acting on muscles, subsequent encounter
- T48.205SAdverse effect of unspecified drugs acting on muscles, sequela
- T48.206AUnderdosing of unspecified drugs acting on muscles, initial encounter
- T48.206DUnderdosing of unspecified drugs acting on muscles, subsequent encounter
- T48.206SUnderdosing of unspecified drugs acting on muscles, sequela
- T48.295AAdverse effect of other drugs acting on muscles, initial encounter
- T48.295DAdverse effect of other drugs acting on muscles, subsequent encounter
- T48.295SAdverse effect of other drugs acting on muscles, sequela
- T48.296AUnderdosing of other drugs acting on muscles, initial encounter
- T48.296DUnderdosing of other drugs acting on muscles, subsequent encounter
- T48.296SUnderdosing of other drugs acting on muscles, sequela
- T48.3X5AAdverse effect of antitussives, initial encounter
- T48.3X5DAdverse effect of antitussives, subsequent encounter
- T48.3X5SAdverse effect of antitussives, sequela
- T48.3X6AUnderdosing of antitussives, initial encounter
- T48.3X6DUnderdosing of antitussives, subsequent encounter
- T48.3X6SUnderdosing of antitussives, sequela
- T48.4X5AAdverse effect of expectorants, initial encounter
- T48.4X5DAdverse effect of expectorants, subsequent encounter
- T48.4X5SAdverse effect of expectorants, sequela
- T48.4X6AUnderdosing of expectorants, initial encounter
- T48.4X6DUnderdosing of expectorants, subsequent encounter
- T48.4X6SUnderdosing of expectorants, sequela
- T48.5X5AAdverse effect of other anti-common-cold drugs, initial encounter
- T48.5X5DAdverse effect of other anti-common-cold drugs, subsequent encounter
- T48.5X5SAdverse effect of other anti-common-cold drugs, sequela
- T48.5X6AUnderdosing of other anti-common-cold drugs, initial encounter
- T48.5X6DUnderdosing of other anti-common-cold drugs, subsequent encounter
- T48.5X6SUnderdosing of other anti-common-cold drugs, sequela
- T48.6X5AAdverse effect of antiasthmatics, initial encounter
- T48.6X5DAdverse effect of antiasthmatics, subsequent encounter
- T48.6X5SAdverse effect of antiasthmatics, sequela
- T48.6X6AUnderdosing of antiasthmatics, initial encounter
- T48.6X6DUnderdosing of antiasthmatics, subsequent encounter
- T48.6X6SUnderdosing of antiasthmatics, sequela
- T48.905AAdverse effect of unspecified agents primarily acting on the respiratory system, initial encounter
- T48.905DAdverse effect of unspecified agents primarily acting on the respiratory system, subsequent encounter
- T48.905SAdverse effect of unspecified agents primarily acting on the respiratory system, sequela
- T48.906AUnderdosing of unspecified agents primarily acting on the respiratory system, initial encounter
- T48.906DUnderdosing of unspecified agents primarily acting on the respiratory system, subsequent encounter
- T48.906SUnderdosing of unspecified agents primarily acting on the respiratory system, sequela
- T48.995AAdverse effect of other agents primarily acting on the respiratory system, initial encounter
- T48.995DAdverse effect of other agents primarily acting on the respiratory system, subsequent encounter
- T48.995SAdverse effect of other agents primarily acting on the respiratory system, sequela
- T48.996AUnderdosing of other agents primarily acting on the respiratory system, initial encounter
- T48.996DUnderdosing of other agents primarily acting on the respiratory system, subsequent encounter
- T48.996SUnderdosing of other agents primarily acting on the respiratory system, sequela
- T49.0X5AAdverse effect of local antifungal, anti-infective and anti-inflammatory drugs, initial encounter
- T49.0X5DAdverse effect of local antifungal, anti-infective and anti-inflammatory drugs, subsequent encounter
- T49.0X5SAdverse effect of local antifungal, anti-infective and anti-inflammatory drugs, sequela
- T49.0X6AUnderdosing of local antifungal, anti-infective and anti-inflammatory drugs, initial encounter
- T49.0X6DUnderdosing of local antifungal, anti-infective and anti-inflammatory drugs, subsequent encounter
- T49.0X6SUnderdosing of local antifungal, anti-infective and anti-inflammatory drugs, sequela
- T49.1X5AAdverse effect of antipruritics, initial encounter
- T49.1X5DAdverse effect of antipruritics, subsequent encounter
- T49.1X5SAdverse effect of antipruritics, sequela
- T49.1X6AUnderdosing of antipruritics, initial encounter
- T49.1X6DUnderdosing of antipruritics, subsequent encounter
- T49.1X6SUnderdosing of antipruritics, sequela
- T49.2X5AAdverse effect of local astringents and local detergents, initial encounter